Navigation Links
Mylan Launches Generic Version of Uroxatral® Tablets
Date:8/12/2011

PITTSBURGH, Aug. 12, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg. This product is the generic version of Uroxatral®, a treatment for signs and symptoms of benign prostatic hyperplasia, or an enlarged prostate.

Uroxatral® Tablets had U.S. sales of approximately $241 million for the 12 months ending June 30, 2011, according to IMS Health.

Currently, Mylan has 162 ANDAs pending FDA approval representing $94.4 billion in annual sales, according to IMS Health. Forty-three of these pending ANDAs are potential first-to-file opportunities, representing $25.5 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
2. Mylan Launches First Generic Version of Entocort EC® Capsules
3. Mylan Receives Approval for Generic Version of Aricept® Tablets
4. Mylan Receives Approval for Generic Version of Effexor XR® Capsules
5. Mylan Launches Generic Version of Roxicodone® Tablets
6. Mylan Launches Generic Version of Depakote® Sprinkle Capsules
7. Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution
8. Mylan Launches First Generic Version of Amrix® Capsules
9. Mylan Launches Generic Version of Risperdal® M-Tab®
10. Mylan Launches First Generic Version of Femara® Tablets
11. Mylan Launches Generic Version of Famvir® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Palatin Technologies, Inc. (NYSE MKT: ... peptide therapeutics for the treatment of diseases ... potential, today announced results for its first ... Recent Highlights , Bremelanotide development ... ($9.8M) total upfront payment - License, co-development ...
(Date:11/17/2014)... STAAR Surgical Company (NASDAQ: STAA ... lenses and delivery systems for the eye, today announced ... Medical Technology & Diagnostics Forum in New ... Thursday, November 20 at 12:30 p.m. PT/3:30 p.m. ET. ... of the Company,s current business trends, financial results, and ...
(Date:11/17/2014)... Wilson Therapeutics AB, a development stage biopharmaceutical company, ... study to evaluate efficacy and safety of its lead ... disorder and designated orphan disease, in which the body ... delighted to proceed with this important clinical study in ... development program for WTX101," said David Clark , ...
Breaking Medicine Technology:Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 4Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 5Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 6Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 7STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
... Nov. 11, 2011 Boston Scientific Corporation (NYSE: ... EVOLVE First Human Use trial demonstrating the non-inferiority ... the PROMUS Element™ Everolimus-Eluting Stent System in treating ... trial provided 30-day clinical and six-month angiographic primary ...
... At a special ceremony at the National Hemophilia ... members of the hemophilia community commemorated the successful conclusion ... ), an innovative interactive contest that raises awareness and ... also kicked off year two of the Virtual Walk ...
Cached Medicine Technology:Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 2Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 3Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 4Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent 5Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders 2Bayer Virtual Walk for Hemophilia Raises Awareness and Funds for People With Bleeding Disorders 3
(Date:11/18/2014)... Sometimes at inopportune times during hectic ... like unforeseen error messages or paper jams. This ... find another printer and they don’t know who is ... likely tied up with other mission-critical projects in their ... Electronic Systems, Inc. (ESI) comes in. Since ...
(Date:11/18/2014)... Sorrel Sky Gallery welcomes jewelry artist ... of her beautiful, one-of-a-kind pieces. Just in time for the ... gallery, Friday, December 5 from 5 – 7:30 p.m. for ... artistic creations began at her grandmother’s kitchen table at a ... designs. She studied at the Gemological Institute of America in ...
(Date:11/18/2014)... Recently, Wigsbuy has introduced its newest collection of ... greatly discounted prices now, up to 85% off. , Wigsbuy ... products, offering many real and synthetic hair products. In order ... uses high quality materials to make its hair wigs, which ... , “We are offering a full line of human ...
(Date:11/18/2014)... -- Hispanic women who,ve had at least five children are ... trouble than those who,ve had fewer children or none, a ... Shivani Aggarwal of Wake Forest School of Medicine analyzed data ... New York City and San Diego. About 12 percent of ... A type of heart trouble called ventricular diastolic dysfunction -- ...
(Date:11/18/2014)... By Dennis Thompson ... -- Otherwise healthy people on the verge of burning out ... research. Those suffering from so-called vital exhaustion -- a ... 36 percent increased risk of developing heart disease, researchers report. ... lot of stress. And I think, when that stress is ...
Breaking Medicine News(10 mins):Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:It Is The Most Wonderful Time To Buy Full Lace Wigs At Wigsbuy.com 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3
... , The partnership will bridge diabetes ... ORLANDO, Fla., Aug. 17 Florida Hospital and Burnham ... giant step in advancing Orlando as a hub for medical ... together to announce the appointment of Dr. Steven R. Smith, ...
... , MILWAUKEE, Aug. 17 ... the top performing health system in the country in a national ... initiative. This is the second consecutive year that Aurora has ... Demonstration project that involves 250 hospitals from across the country. , ...
... study finds small stature not a problem , , MONDAY, ... their short child will be psychologically damaged from merciless teasing, ... no lasting effects from any exposure to short jokes. , ... Pediatrics , found that short children reported being teased only ...
... , , , ... the incidence of skin cancer at a time when melanoma rates ... the Women,s Dermatologic Society (WDS ) will offer free skin ... ages at the world-class LPGA Solheim Cup and the PING Junior ...
... It’s not ... hold. Dr. Jack P. Gunter and his elite team of cosmetic specialists are giving patients ... best for that particular patient after cosmetic enhancement procedures before they even set foot inside ... (Vocus) ...
... ... ... one of the nation,s largest providers of specialty products and services for the workers, compensation market, ... , , ,"We are excited to have Lori join PMSI in this critical role. She is ...
Cached Medicine News:Health News:Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 2Health News:Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute 3Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 2Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 3Health News:Aurora Health Care Top Performing Health System in National Quality Initiative 4Health News:For Short Kids, No Lack of Self-Esteem 2Health News:For Short Kids, No Lack of Self-Esteem 3Health News:Illinois Dermatologists Tee Up for Sun Safety at Two World-Class Golf Championships 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 2Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 3Health News:Dr. Jack P. Gunter Offers 3D Imaging for Dallas, Texas Plastic Surgery Patients 4Health News:PMSI Appoints Lori Daugherty as President of Pharmacy Division 2
Iron Total (TIBC) (Iron Buffer + Iron Color=Std.). An Automated analyzer test kits....
For the quantitative determination of iron, total iron-binding capacity in human serum....
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol, liquid....
Medicine Products: